arrow
S

Suprabhat Giri

Kalinga Institute of Medical Sciences
H指数:15
被引数:995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transdermal buprenorphine versus intravenous tramadol for pain management in acute pancreatitis: A prospective randomized controlled trial

经皮布托啡诺与静脉注射曲马多在急性胰腺炎疼痛管理中的比较:一项前瞻性随机对照试验

2026-11-020
PRE
Outcomes after technically successful transjugular intrahepatic portosystemic shunt for conventional indications and high-risk clinical subgroups: a multicenter cohort study

经颈静脉肝内门体分流术技术成功后,常规适应证和高风险临床亚组的结局:一项多中心队列研究

2026-09-290
OAAI
Portal vein thrombosis (PVT): the Indian National Association for Study of the Liver (INASL) recommendations for management

门静脉血栓形成(PVT):印度肝病研究全国协会(INASL)的管理建议

2026-09-220
PRE
Fecal Impaction: A Costly and Overlooked Consequence of Constipation-Who's at Risk and Who Pays the Price?

粪嵌塞:便秘的一种代价高昂且被忽视的后果——谁有风险,谁承担代价?

2025-10-010
PRE
Stalled Bowels, Strained Hearts: Constipation as a Hidden Risk Factor Independently Predicts Major Cardiovascular Events

肠梗阻,心力竭:便秘作为独立预测主要心血管事件的隐藏风险因素

2025-10-010
PRE
Effect of oral rifaximin for prevention of infected pancreatic necrosis and mortality in severe acute pancreatitis: An open-label randomized controlled trial

奥曲肽口服对预防重症急性胰腺炎感染性胰腺坏死和死亡率的影响:一项开放标签随机对照试验

2025-09-160
PRE
Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia-Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021

肝硬化的代谢原因是亚洲-大洋洲地区原发性肝癌的新病因: 全球疾病负担 (GBD) 研究2021分析

2025-02-010
PRE